Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Pr
10 August 2009 - 8:00PM
PR Newswire (US)
New Product Agreements Complement and Further Enhance Medical
Product Offering BETHESDA, Md., Aug. 10 /PRNewswire-Asia/ --
Chindex International, Inc. ("Chindex") (NASDAQ:CHDX), a leading
independent American provider of Western healthcare products and
services in the People's Republic of China, today announced that it
has entered into two new exclusive, multi-year distribution
agreements for China with Biotest AG and Cutera Inc. Biotest AG,
based in Dreieich, Germany (SDAX: BIO3), specializes in innovative
hematology and immunology products. Biotest has appointed Chindex
as the exclusive distributor for its unique Tango Optimo Automated
Blood Bank System for the People's Republic of China. The Tango
Optimo automates all routine testing procedures performed in blood
banking, including blood grouping, antibody screening, and cross
matching, and is the only blood bank analyzer that offers seven-day
on-board storage of liquid and microplate reagents. Upon receipt of
regulatory approval from China's State Food and Drug
Administration, Chindex will market the Tango Optimo to hospital
laboratories along with the Johnson & Johnson Ortho Clinical
Diagnostics line of clinical chemistry analyzers. Cutera Inc.
(NASDAQ:CUTR) is a leading manufacturer of upgradeable, easy-to-use
laser and other light-based aesthetic systems used by physicians
and other qualified practitioners worldwide. Under the terms of the
agreement, Chindex will market and distribute the upgradeable Xeo,
Solera, and CoolGlide platforms in China and Hong Kong. The Cutera
family of lasers, several of which have already been registered
with the Chinese State Food and Drug Administration, provides an
excellent complement to present Chindex product line. Roberta
Lipson, Chindex President and CEO, commented from Beijing, "We are
excited to be announcing these partnerships with industry-leading
manufacturers that will widen the breadth of products that Chindex
can now offer to China's healthcare communities. Importantly, both
of these exclusive agreements leverage our existing leadership in
their respective target markets in China. Over our 28-year history,
Chindex has installed top quality medical equipment in over 3,000
hospitals throughout China and Hong Kong, many of which are repeat
customers." Today's announcement follows the Company's recently
announced distribution agreement with Vital Images, Inc
(NASDAQ:VTAL), a leading provider of advanced visualization and
analysis software solutions employed by radiologists,
cardiologists, oncologists, and other medical specialists to create
2D, 3D and 4D images of human anatomy from CT and MR image data.
Vital Images' Vitrea(R) software is already approved by the State
Food and Drug Administration for sale in China, and Chindex is
currently marketing the product to hospitals throughout China along
with the innovative imaging products from Siemens and Hologic.
About Chindex International, Inc. Chindex is an American healthcare
company that provides healthcare services and supplies medical
capital equipment, instrumentation and products to the Chinese
marketplace, including Hong Kong. Healthcare services are provided
through the operations of its United Family Hospitals and Clinics,
a network of private primary care hospitals and affiliated
ambulatory clinics in China. The Company's hospital network
currently operates in the Beijing, Shanghai, Guangzhou and Wuxi.
The Company sells medical products manufactured by various major
multinational companies, including Siemens AG and Intuitive
Surgical, for which the Company is the exclusive distribution
partner for the sale and servicing of color ultrasound systems and
surgical robotic systems respectively. It also arranges financing
packages for the supply of medical products to hospitals in China
utilizing the export loan and loan guarantee programs of both the
U.S. Export-Import Bank and the German KfW Development Bank. With
twenty-seven years of experience, approximately 1,300 employees,
and operations in China, Hong Kong, the United States and Germany,
the Company's strategy is to expand its cross-cultural reach by
providing leading edge healthcare technologies, quality products
and services to Greater China's professional communities. Further
company information may be found at the Company's websites
http://www.chindex.com/ and http://www.unitedfamilyhospitals.com/ .
Safe Harbor Statement Statements made in this press release
relating to plans, strategies, objectives, economic performance and
trends and other statements that are not descriptions of historical
facts may be forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended (the
"Securities Act"), and Section 21E of the Securities Exchange Act
of 1934, as amended (the "Exchange Act"). Forward-looking
information is inherently subject to risks and uncertainties, and
actual results could differ materially from those currently
anticipated due to a number of factors, which include, but are not
limited to, the factors set forth under the heading "Risk Factors"
in our annual report on Form 10-K for the year ended March 31,
2009, updates and additions to those "Risk Factors" in our interim
reports on Form 10-Q, Forms 8-K and in other documents filed by us
with the Securities and Exchange Commission from time to time.
Forward-looking statements may be identified by terms such as
"may," "will," "should," "could," "expects," "plans," "intends,"
"anticipates," "believes," "estimates," "predicts," "forecasts,"
"potential," or "continue" or similar terms or the negative of
these terms. Although we believe that the expectations reflected in
the forward-looking statements are reasonable, we cannot guarantee
future results, levels of activity, performance or achievements. We
have no obligation to update these forward-looking statements. For
further information, please contact: Integrated Corporate Relations
Ashley M. Ammon Tel: +1-203-682-8200 DATASOURCE: Chindex
International, Inc. CONTACT: Integrated Corporate Relations, Ashley
M. Ammon, +1-203-682-8200, for Chindex International, Inc. Web
site: http://www.chindex.com/ http://www.unitedfamilyhospitals.com/
Copyright